[18F]-AlF-FAPI-74

DRUG5 trials

Sponsors

St Antonius Hospital, Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Leids Universitair Medisch Centrum (LUMC)

Conditions

Advanced gastric cancerCarcinoma of Unknown PrimaryCholangiocarcinomaProgressive Pulmonary Fibrosis (PPF)

Phase 1

PET/CT imaging with FAPI as a biomarker for the distinction between predominant active fibrotic and inflammatory phenotypes in patients with progressive pulmonary fibrosis: The FIBRO-PET study.

WithdrawnCTIS2023-503686-26-00

St Antonius HospitalProgressive Pulmonary Fibrosis (PPF)

Target: 20Updated: 2024-03-01

PET/CT imaging with FAPI as a biomarker for the distinction between predominant active fibrotic and inflammatory phenotypes in patients with progressive pulmonary fibrosis: The FIBRO-PET study.

RecruitingCTIS2023-503686-26-02

St Antonius HospitalProgressive Pulmonary Fibrosis (PPF)

Start: 2025-01-24Target: 20Updated: 2024-09-20

Phase 2

[18F]FAPI-PET/CT and Laparoscopy in STagIng advanced gastric Cancer – a multicenter prospective study (PLASTIC-3-study)

RecruitingCTIS2024-513255-32-00

Leids Universitair Medisch Centrum (LUMC)Advanced gastric cancer

Start: 2025-07-03Target: 250Updated: 2025-12-03

Phase 3

The effect of [18F]F-FAPI PET-CT on management in patients with potentially resectable biliary tract cancers: prospective multicenter study and cost-effectivity analysis.

RecruitingCTIS2023-507938-24-00

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Cholangiocarcinoma

Start: 2024-11-29Target: 81Updated: 2024-09-16

[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary origin

RecruitingCTIS2023-505592-69-00

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Carcinoma of Unknown Primary

Start: 2024-07-12Target: 50Updated: 2026-01-21